Addressing male HPV vaccination in China: A narrative review of challenges and opportunities
Human papillomavirus (HPV) poses significant health risks to men, including genital warts and HPV-related cancers. In China, the recent approval of HPV vaccination for males aged 9–26 marks an important step toward gender-inclusive prevention. However, challenges remain in promoting vaccine acceptan...
| 出版年: | Human Vaccines & Immunotherapeutics |
|---|---|
| 主要な著者: | , , , , , , |
| フォーマット: | 論文 |
| 言語: | 英語 |
| 出版事項: |
Taylor & Francis Group
2025-12-01
|
| 主題: | |
| オンライン･アクセス: | https://www.tandfonline.com/doi/10.1080/21645515.2025.2552061 |